143 related articles for article (PubMed ID: 7467153)
21. [Total and lipid-bound sialic acids in the blood in primary and secondary hyperlipoproteinemias].
Tvorogova MG; Rozhkova TA; Lupanov VP; Liakishev AA; Titov VN
Ter Arkh; 1997; 69(1):23-5. PubMed ID: 9163043
[TBL] [Abstract][Full Text] [Related]
22. [Dyslipidemic patients with coronary cardiopathy. Effect of different doses of OMEGA-3 fatty acids on serum lipids and lipoproteins].
Arteaga A; Villanueva CL; Skorin C; Guasch V; Solís de Ovando F; Velasco N; Acosta AM; Leighton F
Rev Med Chil; 1993 Jun; 121(6):618-25. PubMed ID: 8278696
[TBL] [Abstract][Full Text] [Related]
23. [Dyslipoproteinemias and the circadian variability of the lipid content of the blood in ischemic heart disease].
Seliverstova GP; Oranskiĭ IE
Lab Delo; 1983; (1):14-7. PubMed ID: 6185723
[No Abstract] [Full Text] [Related]
24. [State of lipid and purine metabolism in children with a family history of ischemic heart disease].
Makarova VIu
Pediatriia; 1984 Nov; (11):8-10. PubMed ID: 6527919
[No Abstract] [Full Text] [Related]
25. Kinetic analysis of lipoproteins.
Asmal AC
JAMA; 1985 Feb; 253(7):978-9. PubMed ID: 3968834
[No Abstract] [Full Text] [Related]
26. [Relationship between phenotype and pathophysiology of dyslipoproteinemia].
Takeuchi N
Rinsho Byori; 1984 Jun; 32(6):590-8. PubMed ID: 6387222
[No Abstract] [Full Text] [Related]
27. [Hyperlipoproteinemia in patients hospitalized for ischemic coronary disease and myocardial infarct].
Cisarik F; Gavalec M; Zánová J; Hrbánová Z
Vnitr Lek; 1981 Feb; 27(2):137-41. PubMed ID: 7467156
[No Abstract] [Full Text] [Related]
28. [Biochemical diagnosis of hereditary hyperlipoproteinemias].
Tvorogova MG; Rozhkova TA; Alidzhanova KhG; Semenova OA; Sobolev AV; Kukharchuk VV; Titov VN
Ter Arkh; 1998; 70(4):9-15. PubMed ID: 9612894
[TBL] [Abstract][Full Text] [Related]
29. [Effects of nutrition characteristics on blood lipids in patients with dyslipoproteinemia].
Vorob'eva EN; Varshavskiĭ BIa; Ivanova TV; Tushev AN; Garkol' NS
Vopr Pitan; 2001; 70(4):17-9. PubMed ID: 11550452
[TBL] [Abstract][Full Text] [Related]
30. [Blood lipid composition characteristics in men under 50 who had a myocardial infarct].
Lipovetskiĭ BM; Triufanov VF
Klin Med (Mosk); 1981 Jun; 59(6):50-3. PubMed ID: 7306309
[No Abstract] [Full Text] [Related]
31. New lipoprotein profiles and coronary heart disease. Improving precision of risk.
Nestel PJ
Circulation; 1990 Aug; 82(2):649-51. PubMed ID: 2372911
[No Abstract] [Full Text] [Related]
32. [Genetically caused and rare forms of dyslipoproteinemias].
Lipovetslkiĭ BM; Trofanov VF
Klin Med (Mosk); 1984 Nov; 62(11):102-8. PubMed ID: 6521363
[No Abstract] [Full Text] [Related]
33. Postprandial lipid metabolism in relation to coronary heart disease.
Karpe F
Proc Nutr Soc; 1997 Jul; 56(2):671-8. PubMed ID: 9264117
[No Abstract] [Full Text] [Related]
34. [Classification of hyperlipoproteinemias and interpretation of laboratory parameters].
Herrmann W; Lackner KJ; Schmitz G
Wien Med Wochenschr; 1994; 144(12-13):292-9. PubMed ID: 8650932
[TBL] [Abstract][Full Text] [Related]
35. Plasma concentrations of non-esterified fatty acids in chronic renal failure in the United Arab Emirates.
Gillett MP; Obineche EN; Khan ST; Abdulle AM
Saudi Med J; 2004 Nov; 25(11):1611-6. PubMed ID: 15573187
[TBL] [Abstract][Full Text] [Related]
36. Plasma lipids and lipoprotein reference values, and the prevalence of dyslipoproteinemia in Canadian adults. Canadian Heart Health Surveys Research Group.
MacLean DR; Petrasovits A; Connelly PW; Joffres M; O'Connor B; Little JA
Can J Cardiol; 1999 Apr; 15(4):434-44. PubMed ID: 10322253
[TBL] [Abstract][Full Text] [Related]
37. [Plasma lipids in men with coronary artery disease. Triglyceride-elevating effect of beta-blockaders].
Faergeman O; Schläger J; Efsen F; Meinertz H
Ugeskr Laeger; 1983 Mar; 145(13):978-9. PubMed ID: 6134366
[No Abstract] [Full Text] [Related]
38. Comparative study of lipids in cardiovascular diseases.
Shroff KF; Shah S; Goyal BK; Chakravorti BP
Indian Heart J; 1973 Apr; 25(2):122-5. PubMed ID: 4726261
[No Abstract] [Full Text] [Related]
39. [Effectiveness of nutritional correction in the prevention of ischemic heart disease].
Smoliar VI; Davidenko NV; Smirnova IP
Gig Sanit; 1986 Apr; (4):8-12. PubMed ID: 3710223
[No Abstract] [Full Text] [Related]
40. Separation of VLDL subfractions by density gradient ultracentrifugation.
Zhao SP; Bastiaanse EM; Hau MF; Smelt AH; Gevers Leuven JA; Van der Laarse A; Van't Hooft FM
J Lab Clin Med; 1995 May; 125(5):641-9. PubMed ID: 7738428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
